Childrens Hospital of Philadelphia Newswire

Childrens Hospital of Philadelphia Newswire

Comprehensive Real-Time News Feed for Childrens Hospital of Philadelphia.

Results 1 - 20 of 89 in Childrens Hospital of Philadelphia

  1. Zion, the world's youngest double hand transplant recipient, can now swing a baseball batRead the original story w/Photo

    Wednesday Jul 19 | The Washington Post

    Eight-year-old Zion Harvey underwent an 11-hour procedure involving a 40-person medical team to give him new hands. The Maryland boy lost his hands and feet after suffering an infection as a child.

    Comment?

  2. World's first kid with double hand transplant now plays baseballRead the original story w/Photo

    Wednesday Jul 19 | India.com

    New York, July 19 Ten-year-old Zion Harvey from the US who underwent a double hand transplant two years back - a first in a child - can not only write, feed and dress today but is able to play baseball using both hands. World's first bilateral hand and forearm transplantation in Harvey that heralded a revolution in transplant medicine, has been declared a success, scientists confirmed in notes that have appeared in the prestigious journal The Lancet Child and Adolescent Health.

    Comment?

  3. FDA panel OKs what may soon be first gene therapy approved in U.S.Read the original story w/Photo

    Thursday Jul 13 | WALB-TV Albany

    A U.S. Food and Drug Administration advisory panel on Wednesday gave unanimous approval to what could soon be the first gene therapy to be marketed in the United States. The treatment, called CTL019, genetically tweaks a patient's own immune system cells into what scientists call "a living drug" to battle a form of acute lymphoblastic leukemia , The New York Times reported.

    Comment?

  4. Stand Up To Cancer, St. Baldricks Foundation Hail Green Light for Car T Cell Therapy for LeukemiaRead the original story

    Thursday Jul 13 | PressReleasePoint

    Stand Up To Cancer and the St. Baldrick's Foundation welcomed Wednesday the tentative approval by a Food and Drug Administration advisory committee of a revolutionary new therapy for a deadly form of leukemia, an approach whose development has also been supported by SU2C and St. Baldrick's. When fully commercialized, this therapy will no doubt save the lives of many children and young adults who have had no other effective therapy for relapsed and refractory B-cell acute lymphoblastic leukemia , " said John Maris, MD, a pediatric oncologist at The Children's Hospital of Philadelphia who holds the Giulio D'Angio Chair in Neuroblastoma Research, and leader of the SU2C-St.

    Comment?

  5. Boston Children's named best pediatric hospital for 5th year in rowRead the original story w/Photo

    Tuesday Jun 27 | Boston.com

    Boston's Children's Hospital was named the best pediatric hospital in the country by U.S. News and World Reportfor the fifth year in a row on Tuesday. "It is certainly an honor to be named the number one pediatric hospital in the nation by U.S. News & World Report.

    Comment?

  6. Dr. Fayaz Khazi, Named President Of Precision BioSciences' PlantSciences UnitRead the original story

    Jun 20, 2017 | Agri Marketing

    DR. FAYAZ KHAZI, NAMED PRESIDENT OF PRECISION BIOSCIENCES' PLANTSCIENCES UNIT Jun. 21, 2017 Source: Precision BioSciences news release Precision BioSciences has appointed Fayaz Khazi, Ph.D., to serve as the President of Precision PlantSciences, a business unit developing innovative, high impact products in the food and agriculture sectors aligned with Precision's overall mission to improve life through scientific innovation. "I am thrilled to welcome Fayaz Khazi to the Precision team," said Matthew Kane, Chief Executive Officer of Precision BioSciences.

    Comment?

  7. Genome-Wide Association Studies and Meta-Analyses for Congenital Heart Defects [Original Articles]Read the original story

    May 3, 2017 | Circulation

    From the Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, UTHealth School of Public Health, Houston ; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia ; and Division of Cardiology , Center for Applied Genomics , and Department of Biomedical and Health Informatics , The Children's Hospital of Philadelphia, PA.

    Comment?

  8. Precision BioSciences Welcomes Ph.D. As President Of PlantsciencesRead the original story

    Jun 19, 2017 | BioSpace

    Precision BioSciences has appointed Fayaz Khazi, Ph.D., to serve as the President of Precision PlantSciences, a business unit developing innovative, high impact products in the food and agriculture sectors aligned with Precision's overall mission to improve life through scientific innovation. "I am thrilled to welcome Fayaz Khazi to the Precision team," said Matthew Kane, Chief Executive Officer of Precision BioSciences.

    Comment?

  9. Precision BioSciences Welcomes Fayaz Khazi, Ph.D. as President of PlantSciencesRead the original story

    Jun 19, 2017 | Customer Interaction Solutions

    Precision BioSciences has appointed Fayaz Khazi, Ph.D., to serve as the President of Precision PlantSciences, a business unit developing innovative, high impact products in the food and agriculture sectors aligned with Precision's overall mission to improve life through scientific innovation. "I am thrilled to welcome Fayaz Khazi to the Precision team," said Matthew Kane, Chief Executive Officer of Precision BioSciences.

    Comment?

  10. Protein network signals found to drive myeloid leukemiasRead the original story w/Photo

    Jun 16, 2017 | Medical News Today

    Researchers have uncovered how mutations in a protein network drive several high-risk leukemias, offering new prospects for novel therapies. An existing drug might be repurposed to treat these leukemias, and the new understanding of the molecular mechanisms at work may offer clues to other drugs yet to be developed.

    Comment?

  11. University City Science Center Release: Three Phase I Ventures...Read the original story

    Jun 12, 2017 | BioSpace

    Three newly formed companies have received $50,000 each from the University City Science Center's Phase 1 Ventures program. PolyCeramX, Recensa Therapeutics and Regennera, all P1V participants, will apply the funds to a combination of technical development and commercialization activities.

    Comment?

  12. Three Phase 1 Ventures Participants Receive Science Center FundingRead the original story

    Jun 13, 2017 | PRWeb

    Three newly formed companies have received $50,000 each from the University City Science Center's Phase 1 Ventures program. Three newly formed companies have received $50,000 each from the University City Science Center's Phase 1 Ventures program.

    Comment?

  13. Zero Suicides? That's the GoalRead the original story w/Photo

    Jun 9, 2017 | NBC Philadelphia

    Dr. Inua Momodu leads a role playing lesson with behavioral health residents at AtlantiCare Regional Medical Center in Pomona, New Jersey. Suicide prevention has been an elusive topic for generations.

    Comment?

  14. The Atlantic is complicit in the Vaccine Holocaust by blatantly...Read the original story w/Photo

    Jun 6, 2017 | NewsTarget.com

    Olga Khazan is a columnist for The Atlantic, but if you read her article, The Shadow Network of Anti-Vax Doctors , you might think she's employed by big pharma, not a well-respected magazine. In her story she writes, "vaccines are some of the safest and most important preventative-health measures around."

    Comment?

  15. Berger Rental Communities Raising $50,000 for CHOP after Launching New Volunteer InitiativeRead the original story w/Photo

    Jun 5, 2017 | 24-7 Press Release

    Berger Rental Communities has launched a new initiative, BRC Cares, which provides team members, residents, and partners with the ability to contribute and participate in philanthropic causes throughout their local communities. There's no better way to build community spirit than to volunteer our time and energy in service to others.

    Comment?

  16. Dr. Of Children's Hospital of Philadelphia Wins Healthcare Innovator AwardRead the original story

    May 22, 2017 | BioSpace

    PHILADELPHIA, May 22, 2017 /PRNewswire-USNewswire/ -- Bimal Desai, MD, MBI, Assistant Vice President and Chief Health Informatics Officer at Children's Hospital of Philadelphia was honored at the Philadelphia Alliance for Capital and Technologies annual black-tie gala as the winner of this year's Healthcare Innovator award. The awards is given to a company, researcher, or investor who provides innovative solutions that have a positive impact on the quality, cost, and access to healthcare.

    Comment?

  17. A new molecular target to improve neuroblastoma treatmentRead the original story w/Photo

    May 22, 2017 | PhysOrg Weblog

    The annual mortality rate in childhood cancer of the sympathetic nervous system, or neuroblastoma, is 10 per million between the ages of zero and four. A collaborative work between Basque and Valencian researchers has identified some genetic mutations that could improve the treatment of this disease.

    Comment?

  18. QED Program Call for Submissions; Science Center Seeks Academic...Read the original story

    May 19, 2017 | PRWeb

    The University City Science Center is seeking proposals for its QED Proof-of-Concept Program. Academic researchers with technologies ripe for commercialization, and who are affiliated with the 21 partner academic and research institutions in Pennsylvania, New Jersey and Delaware, are encouraged to submit proposals.

    Comment?

  19. PK wants to 'CHOP' cancerRead the original story w/Photo

    May 18, 2017 | The West Milford Messenger

    ... created for quick and easy donation online at www.youcaring.com . Search at the top for "Childrens Hospital of Philadelphia" then page down to the PK entry. Donations will be accepted through May 31 for the "May we C.H.O.P. Childhood Cancer" ...

    Comment?

  20. Santhera to Present Data and Host Symposium on Pulmonary Function in...Read the original story

    May 15, 2017 | GlobeNewswire

    Santhera Pharmaceuticals, a specialty pharmaceutical company focused on the development of innovative treatments for rare mitochondrial and neuromuscular diseases, announces that two posters with data from the positive phase III DELOS trial in patients with Duchenne muscular dystrophy will be presented at the 113th American Thoracic Society International Conference in Washington D.C. Throughout the conference, which runs May 19-24, 2017, Santhera will host a clinical trial booth to inform clinicians on the new SIDEROS trial.

    Comment?